Home The Word Brain	My Amedeo FAQ Privacy About
	CC Journal Club Our weekly journal club for junior residents and medical students

Influenza

Free Subscription 14.04.2025 1 Arch Virol 1 Biochem Biophys Res Commun 1 BMC Pediatr 1 Drug Saf 2 Epidemiol Infect 1 J Clin Microbiol 1 J Gen Virol 2 J Immunol 3 J Infect 2 J Infect Dis 2 J Virol 1 PLoS Biol 15 PLoS One 1 Proc Natl Acad Sci U S A 13 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. HUANG Z, Zhang R, Yao D, Fu H, et al
   Avian influenza A(H5N6) virus detected during live-poultry market surveillance linked to a human infection in Changsha, China, from 2020 to 2023.
   Arch Virol. 2025;170:96.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. ZABRODSKAYA YA, Gavrilova NV, Elpaeva EA, Lozhkov AA, et al
   Corrigendum to "mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro" [Biochem. Biophys. Res. Commun. 738 (2024) 150945].
   Biochem Biophys Res Commun. 2025 Apr 9:151783. doi: 10.1016/j.bbrc.2025.151783.
   PubMed        
   
   

   
   BMC Pediatr

3. VIANA J, Santos JV, Pinto A, Santos A, et al
   Avoidable visits to the paediatric emergency department: associated factors and lessons learned from the pandemic.
   BMC Pediatr. 2025;25:279.
   PubMed         Abstract available
   
   

   
   Drug Saf

4. HAMZAOUI H, Shaum A, Cherkaoui I, Moussa LA, et al
   Assessment of Pharmacovigilance Across University Hospitals in Morocco.
   Drug Saf. 2025;48:527-539.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

5. SUOMENRINNE-NORDVIK A, Leino T, Shubin M, Auranen K, et al
   Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era.
   Epidemiol Infect. 2025;153:e59.
   PubMed         Abstract available
   
   
6. WITTEVEEN-FREIDL G, Lauenborg Moller K, Voldstedlund M, Gubbels S, et al
   Data for action - description of the automated COVID-19 surveillance system in Denmark and lessons learnt, January 2020 to June 2024.
   Epidemiol Infect. 2025;153:e58.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

7. HEIMSCH KC, Stanoeva KR, Mogling R, Kraus A, et al
   External quality assessment of molecular detection and variant typing of SARS-CoV-2 in European expert laboratories in 2023.
   J Clin Microbiol. 2025;63:e0153824.
   PubMed         Abstract available
   
   

   
   J Gen Virol

8. SANCHEZ-MARTINEZ A, Moore T, Freitas TS, Benzaken TR, et al
   Recent advances in the prevention and treatment of respiratory syncytial virus disease.
   J Gen Virol. 2025;106.
   PubMed         Abstract available
   
   

   
   J Immunol

9. HATIPOGLU I, Ainsua-Enrich E, Kadel S, Turner S, et al
   IRF4-regulated transcriptional and functional heterogeneity of lung-resident CD11b+ cDC2 subsets during influenza virus infection.
   J Immunol. 2025 Apr 10:vkaf060. doi: 10.1093.
   PubMed         Abstract available
   
   
10. DINANT S, Castille J, Deloizy C, Bruder E, et al
    The prion-family protein Doppel exerts a protective role during influenza virus infection.
    J Immunol. 2025 Apr 9:vkaf031. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect

11. JIN R, Qin T, Li P, Yuan J, et al
    Increased Circulation of Adenovirus in China During 2023-2024: Association with an Increased Prevalence of Species B and School-Associated Transmission.
    J Infect. 2025 Mar 21:106475. doi: 10.1016/j.jinf.2025.106475.
    PubMed         Abstract available
    
    
12. PEREZ CM, Ruiz-Rius S, Ramirez-Morros A, Vidal M, et al
    Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections.
    J Infect. 2025 Mar 18:106473. doi: 10.1016/j.jinf.2025.106473.
    PubMed         Abstract available
    
    
13. WADIA U, Moore HC, Richmond PC, Levy A, et al
    Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024.
    J Infect. 2025;90:106466.
    PubMed         Abstract available
    
    

    
    J Infect Dis

14. YAMAMOTO S, Mizoue T, Ujiie M, Horii K, et al
    Low levels of post-vaccination hemagglutination inhibition antibodies and their correlation with influenza protection among healthcare workers during the 2024/2025 A/H1N1 outbreak in Japan.
    J Infect Dis. 2025 Apr 10:jiaf183. doi: 10.1093.
    PubMed         Abstract available
    
    
15. LEWIS NM, Harker EJ, Cleary S, Zhu Y, et al
    Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024.
    J Infect Dis. 2025 Apr 8:jiaf185. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

16. XU S, Liu Y, Luo C, Zhou M, et al
    Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin.
    J Virol. 2025 Apr 7:e0209024. doi: 10.1128/jvi.02090.
    PubMed         Abstract available
    
    
17. ADU OF, Sempere Borau M, Fruh SP, Karakus U, et al
    Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors.
    J Virol. 2025 Apr 10:e0227524. doi: 10.1128/jvi.02275.
    PubMed         Abstract available
    
    

    
    PLoS Biol

18. GILBERT SC
    Priorities for rapid and cost-effective vaccines to improve outbreak responses.
    PLoS Biol. 2025;23:e3003114.
    PubMed         Abstract available
    
    

    
    PLoS One

19. BENAVIDES FFW, Veldhuis Kroeze EJB, Leijten L, Schmitz KS, et al
    Neuroinvasive and neurovirulent potential of SARS-CoV-2 in the acute and post-acute phase of intranasally inoculated ferrets.
    PLoS One. 2025;20:e0311449.
    PubMed         Abstract available
    
    
20. KAMO M, Murakami M, Naito W, Yasutaka T, et al
    Comparison of COVID-19 testing strategies and costs for professional sports teams: A case study of J. League clubs.
    PLoS One. 2025;20:e0310939.
    PubMed         Abstract available
    
    
21. USTUNDAG MG, Beyhun NE, Topbas M, Turhan S, et al
    Direct medical cost of adult Covid-19 inpatients and its determinants at a university hospital.
    PLoS One. 2025;20:e0319762.
    PubMed         Abstract available
    
    
22. YEHIA AC, Moreira J, Premaor MO
    Burnout syndrome in resident physicians: A study after the third COVID-19 wave in two tertiary hospitals of southeastern Brazil.
    PLoS One. 2025;20:e0321443.
    PubMed         Abstract available
    
    
23. GABRIELA BAYOLO S, Miraine Davila F, Gayraud G
    Test allocation based on risk of infection from first and second order contact tracing.
    PLoS One. 2025;20:e0320291.
    PubMed         Abstract available
    
    
24. BOZIC A, Podgornik R
    Increased preference for lysine over arginine in spike proteins of SARS-CoV-2 BA.2.86 variant and its daughter lineages.
    PLoS One. 2025;20:e0320891.
    PubMed         Abstract available
    
    
25. LI F, Tong M, Guan S
    Changes in the network structure of energy markets and financial markets under the different shocks of the Russia-Ukraine conflict and COVID-19.
    PLoS One. 2025;20:e0318291.
    PubMed         Abstract available
    
    
26. HERBERHOLZ C, Saichol P, Damrongplasit K
    Health insurance type, healthcare utilization and out-of-pocket expenditure in the face of COVID-19: Evidence from Thai national survey data.
    PLoS One. 2025;20:e0321468.
    PubMed         Abstract available
    
    
27. QUIROS-RAMIREZ MA, Feineisen A, Streuber S, Reips UD, et al
    Virtual Reality experiments in the field.
    PLoS One. 2025;20:e0318688.
    PubMed         Abstract available
    
    
28. ADEWOPO J, Andree BPJ, Peter H, Solano-Hermosilla G, et al
    AI-imputed and crowdsourced price data show strong agreement with traditional price surveys in data-scarce environments.
    PLoS One. 2025;20:e0320720.
    PubMed         Abstract available
    
    
29. ASTETE CORNEJO J, Cruz-Ausejo L, Cainamarks Alejandro J, Burgos-Flores MA, et al
    Barriers and limitations to the development of a telemental health service for workers in Peru- A user-centered approach.
    PLoS One. 2025;20:e0321401.
    PubMed         Abstract available
    
    
30. SHAW RJ, Hamilton OKL, Rhead R, Silverwood RJ, et al
    Associations between different measures of SARS-CoV-2 infection status and subsequent economic inactivity: A pooled analysis of five longitudinal surveys linked to healthcare records.
    PLoS One. 2025;20:e0321201.
    PubMed         Abstract available
    
    
31. VO DH, Huynh TL, Ho CM, Vo QT, et al
    The impact of social welfare support on mental health in Vietnam.
    PLoS One. 2025;20:e0318374.
    PubMed         Abstract available
    
    
32. HE T, Tu CC, Wang Z, Hao D, et al
    Potential effect of social support on perceived stress and anxiety in college students during public health crisis: Multiple interactions of gender.
    PLoS One. 2025;20:e0319799.
    PubMed         Abstract available
    
    
33. J VK, Koshy JM, S D, Narreddy S, et al
    Prevalence and predictors of long COVID at 1 year in a cohort of hospitalized patients: A multicentric qualitative and quantitative study.
    PLoS One. 2025;20:e0320643.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

34. LIU X, Balligand T, Le Gall C, Ploegh HL, et al
    A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses.
    Proc Natl Acad Sci U S A. 2025;122:e2424889122.
    PubMed         Abstract available
    
    

    
    Vaccine

35. BERGSTROM F, Gunther F, Britton T
    A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden.
    Vaccine. 2025;52:126870.
    PubMed         Abstract available
    
    
36. DUDLEY MZ, Zapf AJ, Delamater P, Proveaux TM, et al
    Attitudes of California school personnel on potential COVID-19 vaccine mandates and state law SB277 to remove nonmedical vaccine exemptions.
    Vaccine. 2025;52:126888.
    PubMed         Abstract available
    
    
37. ANDERSEN KM, Allen KE, Nepal RM, Mateus JS, et al
    Effectiveness of BNT162b2 XBB.1.5 vaccine in immunocompetent adults using tokenization in two U.S. states.
    Vaccine. 2025;52:126881.
    PubMed         Abstract available
    
    
38. LEBLANG D, Smith MD, Wesselbaum D
    Global perspectives on COVID-19 vaccination: Impacts on well-being and inequality.
    Vaccine. 2025;52:126906.
    PubMed         Abstract available
    
    
39. DIYA O, Gayed J, Lowry FS, Ma H, et al
    A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults >/=18 years old.
    Vaccine. 2025;52:126869.
    PubMed         Abstract available
    
    
40. MATHUR I, Ruisch A, Conlin M, Oyatoye I, et al
    COVID-19 vaccination integration, innovations and key populations: Results from a global survey.
    Vaccine. 2025;52:126863.
    PubMed         Abstract available
    
    
41. CHU CF, Chang TH, Ho JJ
    Comparative analysis of fourteen COVID-19 vaccine injury compensation systems and claim approval rates.
    Vaccine. 2025;52:126830.
    PubMed         Abstract available
    
    
42. PEIXOTO DE MIRANDA EJF, Calado RT, Boulos FC, de Sousa Moreira JA, et al
    Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil.
    Vaccine. 2025;52:126680.
    PubMed         Abstract available
    
    
43. BOLU O, Alo OD, Iwara E, Longley AT, et al
    Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021.
    Vaccine. 2025;52:126907.
    PubMed         Abstract available
    
    
44. CHEN PL, Richardson RA, Rovito S, Yang G, et al
    Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets.
    Vaccine. 2025;53:127090.
    PubMed         Abstract available
    
    
45. LLOYD PC, Acharya G, Zhao H, Shah N, et al
    Safety monitoring of health outcomes following influenza vaccination during the 2023-2024 season among U.S. Medicare beneficiaries aged 65 years and older.
    Vaccine. 2025;53:127069.
    PubMed         Abstract available
    
    
46. ZASZTOWT-STERNICKA M, Jagielska A, Rzad M, Szymusik I, et al
    Immunogenicity of inactivated quadrivalent influenza vaccine in pregnant women, including the level of postvaccination antibodies in umbilical cord blood.
    Vaccine. 2025;53:127047.
    PubMed         Abstract available
    
    
47. ZHANG L, Xia Y, Chu L, Sundaram ME, et al
    Differences in seasonal influenza vaccine hesitancy profiles between clinicians practicing traditional Chinese medicine and modern Western medicine: A national cross-sectional survey.
    Vaccine. 2025;53:127106.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.